How should fever that occurs during a post‑exposure anti‑rabies vaccination series be managed?

Management of Fever During Anti-Rabies Vaccination

Continue the rabies post-exposure prophylaxis series without interruption when fever develops, as fever is a common and expected adverse effect that does not require discontinuation of vaccination. 1

Key Management Principles

Do Not Stop the Vaccine Series

The most critical point is that rabies PEP must be completed regardless of fever or other mild-to-moderate adverse effects, as rabies is nearly 100% fatal once clinical symptoms develop. The ACIP guidelines explicitly note that adverse events, including fever, were not correlated with vaccine failure, and the overall safety profile supports continuation 1.

Expected Adverse Effects

Fever is a recognized systemic adverse effect of rabies vaccination, occurring in approximately 7.4% of recipients 2. Other common symptoms include:

• Tiredness (30.6%)
• Malaise (26.4%)
• Headache (26.9%)
• Dizziness (14.8%)
• Chills (13.0%)

Important distinction: While symptoms like tiredness, malaise, headache, dizziness, and chills tend to decline with subsequent doses, fever incidence remains relatively constant throughout the series 2.

Symptomatic Management

For Simple Fever

• Administer antipyretics (acetaminophen or NSAIDs) for symptomatic relief
• Provide reassurance that this is an expected reaction
• Strongly encourage completion of the full vaccine series 2

Red Flags Requiring Further Evaluation

While fever alone should not stop vaccination, evaluate for more serious reactions:

Serum sickness-like reactions (typically develop 7-10 days after immunoglobulin administration):

• Urticarial or maculopapular rash starting at injection site
• Fever with arthralgias
• Lymphadenopathy
• These require treatment with antihistamines and potentially corticosteroids, but vaccination should still continue 3, 4

Severe neurological symptoms warranting discontinuation (rare, ~5% discontinuation rate):

• Strong, persistent headache with meningeal signs
• Significant paraesthesias
• Severe systemic reactions preventing continuation 2

Clinical Algorithm

1. Assess fever severity and associated symptoms

   • Isolated low-grade fever → Continue series with symptomatic treatment
   • Fever with rash appearing 7-10 days post-HRIG → Consider serum sickness, treat symptomatically, continue series
   • Fever with severe headache and meningeal signs → Evaluate for aseptic meningitis, but strongly consider continuing if no alternative diagnosis

2. Provide symptomatic relief

   • Antipyretics as needed
   • Antihistamines if urticaria present
   • Short course of corticosteroids for serum sickness-like reactions 3

3. Continue scheduled vaccination

   • Day 0,3,7, and 14 for previously unvaccinated persons 1
   • Do not delay or skip doses due to fever alone

Critical Pitfall to Avoid

Never discontinue rabies PEP for mild-to-moderate adverse effects including fever. The mortality rate of untreated rabies approaches 100%, while the vaccine series is nearly 100% effective when completed appropriately 5. Only severe, life-threatening reactions should prompt consideration of discontinuation, and even then, consultation with infectious disease specialists and public health authorities is essential before stopping prophylaxis.